StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-11 | $0.82 | $0.82 | +0.00% | 0.0M |
| 05-19 | $0.73 | $0.84 | +15.07% | 0.0M |
| 05-22 | $0.79 | $0.82 | +3.80% | 0.0M |
| 05-26 | $0.83 | $0.83 | +0.00% | 0.0M |
| 05-27 | $0.80 | $0.80 | +0.00% | 0.0M |
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2015 2015-03-31 | Annual 2014 2014-12-31 | Q3 2014 2014-09-30 | Q2 2014 2014-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-587.74K | $-4.06M | $-2.51M | $-1.79M |
Net Income | $-556.64K | $-4.06M | $-2.49M | $-1.81M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $407.16K | $123.11K | $273.00K | $1.09M |
Total Liabilities | Not available | $3.91M | Not available | Not available |
Cash & Equivalents | $276.48K | $19.48K | $104.09K | $889.33K |
Free Cash Flow OCF − CapEx | Not available | $-3.12M | $2.93M | $2.15M |
Shares Outstanding | 23.58M | 23.58M | 23.58M | 23.25M |
No sell-side coverage available for CLCS yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
CELL SOURCE INC
Fundamentals not available for CLCS yet.
We pull from FMP, Finnhub, and Polygon — common gaps are very recent IPOs that haven't filed their first 10-Q, pink-sheet OTC tickers, and foreign filers without US-listed depth. The Financials tab reads SEC EDGAR directly and may still have data here.